Picture of Dare Bioscience logo

DARE Dare Bioscience Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual income statement for Dare Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue000010
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses16.914.327.438.741.4
Operating Profit-16.9-14.3-27.4-38.7-31.4
Other Net Non Operating Costs
Net Income Before Taxes-16.7-14.3-27.4-38.7-30.9
Net Income After Taxes-16.7-14.3-27.4-38.7-30.9
Net Income Before Extraordinary Items
Net Income-16.7-14.3-27.4-38.7-30.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-16.7-15.1-27.4-38.7-30.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.08-0.966-0.911-0.639-0.366